Search results
Results from the WOW.Com Content Network
GxP is a general abbreviation for the "good practice" quality guidelines and regulations. The "x" stands for the various fields, including the pharmaceutical and food industries, for example good agricultural practice, or GAP. A "c" or "C" is sometimes added to the front of the initialism.
Good documentation practice (recommended to abbreviate as GDocP to distinguish from "good distribution practice" also abbreviated GDP) is a term in the pharmaceutical and medical device industries to describe standards by which documents are created and maintained.
Title 21 is the portion of the Code of Federal Regulations that governs food and drugs within the United States for the Food and Drug Administration (FDA), the Drug Enforcement Administration (DEA), and the Office of National Drug Control Policy (ONDCP). [1] It is divided into three chapters: Chapter I — Food and Drug Administration
The Alcoa Steamship Company was a subsidiary of ALCOA since the company was formed in 1917. [68] List of ships: SS Alcoa Banner (SS Sundance) [69] SS Alcoa Cavalier; SS Alcoa Clipper; SS Alcoa Corsair; SS Alcoa Guide [70] SS Alcoa Partner; SS Alcoa Patriot; SS Alcoa Pegasus; SS Alcoa Pennant; SS Alcoa Pilgrim; SS Alcoa Pioneer [71] [72] SS ...
Boeing and Alcoa Form 'Closed-Loop' Program To Boost Recycling of Aluminum Aerospace Alloys Program Also Lays Framework to Expand Recycling to Broader Supply Chain and All Forms of Aluminum LE ...
On Monday, the U.S. Food and Drug Administration (FDA) announced that, for the first time, it is setting guidelines for an acceptable level of lead in processed baby food, including canned fruit ...
FDA Building 32 houses the Office of the Commissioner and the Office of Regulatory Affairs. The Office of Global Regulatory Operations and Policy (GO), [1] also known as the Office of Regulatory Affairs (ORA), [2] is the part of the U.S. Food and Drug Administration (FDA) enforcing the federal laws governing biologics, cosmetics, dietary supplements, drugs, food, medical devices, radiation ...
Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book, is a publication produced by the United States Food and Drug Administration (FDA), as required by the Drug Price and Competition Act (Hatch-Waxman Act). The Hatch-Waxman Act was created to '"strike a balance between two competing policy interests: